LRRK2 and Parkinson disease: However, its correlation with HPgV titer was genotype specific: in PD-LRRK2 HPgV+ patients, IL-4 signaling decreased as HPgV titer increased, whereas in PD-WT HPgV+ patients, IL-4 signaling increased with rising HPgV titer.